Blog The Three-Room PCR Strategy: Designing a Laboratory Where Contamination Has Nowhere to Go

The Three-Room PCR Strategy: Designing a Laboratory Where Contamination Has Nowhere to Go

1 hour ago

The Result Is Only as Reliable as the Room That Produced It

A molecular diagnostic laboratory can produce an elegant amplification curve, a clean report, and a clinically important result.

Yet the result may still be wrong.

The problem is not always the assay design. Sometimes it is a pipette that crossed a doorway. A glove that touched a contaminated tube and then a reagent bottle. A tube rack that looked harmless but carried thousands of amplicon copies from yesterday's run.

PCR is powerful because it can find an almost invisible signal. That same sensitivity means the laboratory must control what enters the reaction with unusual discipline.

A single aerosolized amplicon can look like a patient's true positive.

This is why contamination control is not a cleaning task added to the end of a workflow. It is a facility-design problem, a human-behavior problem, and a systems-engineering problem.

The three-room strategy addresses all three.

It separates the PCR workflow into:

  1. A Clean room for reagent preparation.
  2. A Grey room for sample extraction and template addition.
  3. A Dirty room for amplification and post-PCR detection.

The design follows one physical rule:

Materials and personnel move from clean to dirty, and never in reverse.

When the layout, equipment, airflow, and staff behavior all support that rule, contamination loses its easiest route back into the assay.

Why PCR Contamination Is So Difficult to See

PCR Creates Its Own Future Contaminant

Every successful amplification creates an enormous number of copies of the target sequence.

That is the purpose of PCR. It is also the source of its most persistent vulnerability.

After amplification, a tube may contain millions of copies of a sequence that was initially present in only a few molecules. If that tube is opened, droplets or microscopic particles can escape. Those particles may settle on a bench, a glove, a pipette shaft, or the handle of a drawer.

The contamination may be invisible.

The next day, a technician can prepare a fresh master mix on the same bench. Nothing looks unusual. The reagents are within specification. The instrument passes its checks.

Then the target appears in a negative sample.

The laboratory has not detected the patient. It has detected its own history.

The Psychology of a False Positive

False positives are particularly dangerous because they often feel convincing.

A positive result carries narrative weight. It can trigger treatment, isolation, additional procedures, and emotional distress. Once reported, it is difficult to treat the result as a simple technical event. The patient and clinician experience it as information about a person.

This creates a psychological asymmetry:

  • A false negative may be questioned when symptoms persist.
  • A false positive can immediately change a patient's care.
  • A clean-looking run can create unjustified confidence.
  • A familiar workflow can hide a familiar failure.

The technician is rarely careless in any dramatic sense. Most contamination events come from ordinary decisions made under pressure:

  • Borrowing a pipette because another one is being serviced.
  • Walking back through a room to retrieve a forgotten notebook.
  • Removing gloves in the wrong location.
  • Opening a post-PCR tube because the result needs confirmation.
  • Treating a small accessory as too insignificant to require room ownership.

Good laboratory design assumes that people will sometimes be hurried, distracted, or interrupted. It makes the correct behavior easier than the incorrect behavior.

The Three-Room Strategy as a Physical Barrier

The three-room model turns the PCR process into a one-way production line.

The Clean room starts the process. The Grey room introduces biological material. The Dirty room receives sealed reactions and handles amplification products.

Each room has a defined purpose and a defined level of risk.

Room Primary function Contamination risk Core controls
Clean room Reagent preparation and master-mix setup Exposure to target DNA/RNA or amplicons Positive pressure where appropriate, HEPA filtration, dedicated reagents and pipettes
Grey room Sample extraction and template/control addition Biological specimens and positive controls Dedicated extraction equipment, controlled access, room-specific consumables
Dirty room Amplification and post-PCR detection High-copy amplicons and aerosols Negative pressure where feasible, sealed reaction transfer, permanent equipment isolation

The rooms do not merely divide tasks.

They divide the consequences of failure.

A contamination event in the Dirty room should remain in the Dirty room. A reagent-preparation error in the Clean room should be discoverable through controls before it becomes a patient result. Physical separation gives the laboratory time and space to detect problems before they propagate.

Room 1: The Clean Room Protects the Starting Point

The Clean room is where the assay begins.

This room is used for preparing master mixes, dispensing amplification reagents, and organizing materials that have not yet encountered patient samples, positive controls, or amplified products.

Its defining characteristic is exclusion.

The following materials should never enter:

  • Target nucleic acids.
  • Positive control DNA or RNA.
  • Extracted patient samples.
  • Opened post-amplification tubes.
  • Consumables or equipment from the Grey or Dirty rooms.

The room should have dedicated:

  • Pipettes.
  • Filtered pipette tips.
  • Reagent racks.
  • Tube openers.
  • Lab coats and gloves.
  • Waste containers.
  • Documentation materials.

Air handling should support the room's role as the protected starting point. Positive pressure or HEPA filtration may be appropriate depending on the facility design, assay risk, and applicable requirements.

The exact infrastructure matters, but the behavioral rule matters more:

Nothing that has touched a target sequence should be allowed to define the baseline of a fresh reaction.

Master mixes are often treated as inert materials. They are not. They are highly receptive environments for contamination because they are designed to support amplification.

A contaminated master mix can turn an entire batch into a coherent-looking failure.

Room 2: The Grey Room Connects the Assay to the Patient

The Grey room is where the clean chemistry meets biological reality.

This is the appropriate location for:

  • Receiving and processing specimens.
  • Extracting DNA or RNA.
  • Adding patient templates to reaction mixtures.
  • Handling positive controls.
  • Managing the transition from prepared reagent to sealed reaction.

The Grey room is not clean in the same sense as the reagent room. It contains biological samples and target nucleic acids. But it must remain protected from the much higher contamination burden associated with post-amplification material.

Positive controls deserve special attention.

They prove that the assay can detect its target, but they are also concentrated sources of the very sequence the Clean room must avoid. Handling them only in the Grey room preserves the separation between reagent preparation and template addition.

A practical workflow looks like this:

  1. Master mix is prepared in the Clean room.
  2. The prepared mix is transferred into the Grey room.
  3. Patient extracts and positive controls are added.
  4. Reaction tubes are sealed.
  5. Sealed reactions move forward to the Dirty room.
  6. No material returns to the Grey room after amplification.

The Grey room is where many laboratories face their most difficult operational decisions. Staff must manage samples, controls, labels, extraction equipment, and timing without creating shortcuts.

The room should therefore make ownership visible. Equipment labels, color-coded consumables, and clear bench zoning reduce the number of decisions a technician has to make while handling a high-consequence workflow.

Room 3: The Dirty Room Contains the Highest-Risk Material

The Dirty room houses thermal cyclers, real-time PCR instruments, and post-PCR detection equipment.

Everything that has passed through amplification belongs here.

This includes:

  • Amplified reaction tubes.
  • Post-PCR plates.
  • Detection instruments.
  • Tube racks.
  • Pipettes.
  • Tube openers.
  • Waste containers.
  • Gloves, coats, and other protective equipment used during post-PCR work.

The room is called "Dirty" for a reason. It is not a judgment about the quality of the work. It describes the concentration of amplified material present in the environment.

Once an item enters this room, assume it is contaminated with amplicons unless proven otherwise.

Negative pressure can help contain aerosols, especially where tubes are opened for detection or downstream analysis. However, pressure control cannot compensate for a technician carrying a Dirty-room pipette into reagent preparation.

The most important control is permanence:

Post-amplification equipment does not travel backward.

That rule applies to objects that are easy to overlook. A marker, notebook, tube rack, or door handle can become part of the contamination pathway. The smaller the object, the more likely it is to escape attention.

The Unidirectional Workflow Must Include People

A three-room layout can fail even when the walls are correct.

The reason is simple: people are mobile.

Personnel should move only in the following direction during a work session:

Clean → Grey → Dirty

They should not reverse direction to retrieve supplies, check a result, or solve an equipment problem.

Room-specific protective clothing helps reinforce the boundary:

  • Use dedicated, color-coded lab coats.
  • Change gloves when moving between zones.
  • Use room-specific shoe covers where required.
  • Remove or change protective items at the designated exit point.
  • Keep room-specific supplies physically separated.

The objective is not to create ceremonial complexity. It is to prevent unconscious transfer.

A color-coded pipette is a visual control. A bold room label is a memory aid. A pass-through locker is a physical constraint. Together, these controls reduce reliance on perfect attention.

In high-throughput laboratories, this matters even more. The more often a workflow repeats, the more likely a workaround becomes normalized. A shortcut that saves thirty seconds can eventually become the laboratory's unofficial standard operating procedure.

Good design makes the shortcut unnecessary.

Equipment Segregation: Every Object Has a Home

No instrument or accessory that has touched amplified DNA should come near the Clean room.

This includes obvious equipment such as thermocyclers and detection platforms. It also includes objects that appear operationally neutral:

  • Pipettes.
  • Centrifuges.
  • Tube racks.
  • Tip boxes.
  • Tube openers.
  • Markers.
  • Scissors.
  • Notebooks.
  • Waste bins.
  • Cleaning supplies.

Each room should maintain its own inventory.

Equipment category Clean room Grey room Dirty room
Reagent-preparation pipettes Yes No No
Sample-extraction tools No Yes No
Positive-control handling tools No Yes No
Thermal cyclers No No Yes
Post-PCR detection equipment No No Yes
Room-specific protective clothing Yes Yes Yes

When equipment is duplicated, the laboratory pays a financial cost at the beginning.

When equipment is shared, the laboratory pays a reliability cost every day.

The second cost is harder to see. It appears as repeat testing, investigations, delayed reporting, reagent waste, staff fatigue, and uncertainty about which result can be trusted.

For laboratories pursuing ISO 15189 or similar accreditation, the equipment map should be documented and auditable. A room label is useful. A controlled inventory, maintenance record, and transfer policy are stronger evidence that the system is operating as intended.

Airflow Is Part of the Workflow

Amplicons do not move only through hands and equipment. They can also move through air.

Air-pressure design should therefore align with the direction of risk:

  • The Clean room should be protected from ingress of external contaminants.
  • The Grey room should remain an intermediate handling zone.
  • The Dirty room should contain the highest-risk aerosol-generating activities.
  • Air movement should not create a route from Dirty back toward Clean.

Facility constraints often make the ideal design difficult. Existing laboratories may share corridors, ventilation systems, or access points. In these cases, the solution is not to abandon the principle. It is to add layers of control:

  • Use modular partitions to create functional zones.
  • Install dedicated workstations or laminar flow hoods where appropriate.
  • Use pass-through lockers for materials.
  • Mark personnel routes on the floor.
  • Separate gowning and de-gowning points.
  • Review pressure differentials and air-change performance.
  • Document exceptions and compensating controls.

A room is not defined only by its walls. It is defined by what can enter, what can leave, and how reliably those movements are controlled.

Three Rooms Are Necessary, but Not Sufficient

Spatial separation removes a major contamination pathway. It does not remove every pathway.

A complete program should also include:

Enzymatic Contamination Control

UNG/dUTP systems can help prevent carryover from previous PCR products, depending on assay chemistry and validation requirements.

This is a biochemical layer of defense. It should complement, not replace, physical separation.

Routine Decontamination

Use validated DNA-denaturing or nucleic-acid decontamination procedures for benches, instruments, and high-touch surfaces.

Cleaning schedules should specify:

  • What is cleaned.
  • Which agent is used.
  • How often cleaning occurs.
  • Who performs it.
  • How completion is recorded.
  • What happens after a suspected contamination event.

Negative Controls

Negative controls should be included in every run as defined by the assay and quality system.

They provide evidence that the signal is not appearing in the absence of target material. A negative control is not merely a checkbox. It is the laboratory's witness to the integrity of the workflow.

Environmental Monitoring

High-risk or high-throughput laboratories may benefit from periodic environmental monitoring, especially after maintenance, layout changes, unusual control failures, or contamination investigations.

The purpose is not to prove that the laboratory is permanently clean. It is to identify whether contamination has entered a place where it can affect future reactions.

Training and Audits

Training should include the reasoning behind the rules.

People follow procedures more consistently when they understand the asymmetry of PCR: the amount of contamination required to create a problem can be far smaller than the amount visible to the eye.

Unannounced observations can reveal the difference between the written SOP and the real workflow. That difference is where many failures live.

When a Fourth Room Makes Sense

The standard three-room model is sufficient for most diagnostic PCR workflows when it is properly implemented.

Some laboratories introduce a fourth room to separate reagent preparation from template addition even further. This may be justified when:

  • The assay has exceptionally high sensitivity.
  • Positive controls contain highly concentrated target material.
  • The laboratory handles large numbers of samples.
  • The cost of a false positive is unusually high.
  • The facility has repeated contamination events despite corrective action.
  • Regulatory or client requirements demand additional segregation.

More rooms do not automatically create more control.

Each additional room introduces more doors, transfers, gowning steps, inventories, and opportunities for confusion. The right question is not whether four rooms sound safer. It is whether the extra barrier addresses a specific, measured risk.

Choosing the Right Implementation Path

For a New Molecular Laboratory

Design the workflow before designing the rooms.

Map:

  • Personnel movement.
  • Sample movement.
  • Reagent movement.
  • Waste movement.
  • Emergency access.
  • Equipment maintenance.
  • Cleaning routes.

Integrate pass-through windows, controlled doors, dedicated storage, and airflow planning from the start. When the architecture matches the SOP, compliance becomes less dependent on memory.

For an Existing Single-Room Facility

A retrofit can still create meaningful separation.

Use modular partitions, dedicated workstations, room-specific equipment, and visual route markings. If permanent walls are not possible, create functional rooms within the larger space and document the compensating controls.

The system will be weaker than a purpose-built facility if boundaries are ambiguous. That makes discipline, audits, and inventory control even more important.

For an Accreditation-Focused Laboratory

Build the paper trail alongside the physical system.

Maintain records for:

  • Room functions and access permissions.
  • Equipment ownership by room.
  • Cleaning and decontamination.
  • Pressure and environmental checks.
  • Staff training.
  • SOP revisions.
  • Control failures and corrective actions.
  • Internal audits.

Auditors look for more than a floor plan. They look for evidence that the intended workflow is the actual workflow.

For a High-Throughput Laboratory

Plan for failure.

Duplicate small equipment across rooms. Keep replacement pipettes and consumables available in their correct zones. A broken Dirty-room pipette should never create pressure to borrow one from the Clean room.

Throughput is not only the number of tests completed per day. It is the number of valid, reportable results completed without rework.

The Business Case for Contamination Control

Contamination control is often framed as a compliance expense.

That framing is incomplete.

A contamination event consumes:

  • Patient samples.
  • Reagents.
  • Instrument time.
  • Staff hours.
  • Reporting capacity.
  • Investigation resources.
  • Client confidence.

For diagnostic manufacturers, laboratories, and research institutes, the cost can extend into delayed product development, failed validation runs, customer complaints, and damaged credibility.

Reliable infrastructure protects more than a single PCR run. It protects the continuity of the assay lifecycle, from early concept and analytical development to clinical implementation.

That is where an experienced technical partner can add practical value.

CamelBio provides diagnostic manufacturers, laboratories, and research institutes with one-stop access to IVD raw materials, technical services, and consulting. Its support spans the path from concept to clinic, helping teams evaluate materials, strengthen workflows, and make technical decisions that remain workable under real laboratory conditions.

The best solution is rarely one reagent or one room in isolation. It is the coordination of chemistry, equipment, facility design, quality controls, and human behavior.

A Practical Readiness Checklist

Before implementing or auditing a three-room strategy, ask:

  • Is every room's purpose explicitly defined?
  • Can personnel move only from Clean to Grey to Dirty?
  • Are positive controls excluded from the Clean room?
  • Are all post-PCR materials permanently restricted to the Dirty room?
  • Does every pipette and accessory have a labeled room of ownership?
  • Are protective garments changed between zones?
  • Is airflow aligned with the contamination-risk direction?
  • Are sealed reactions transferred without reopening?
  • Are negative controls included and reviewed?
  • Is decontamination documented?
  • Are staff trained on the reason behind each boundary?
  • Can the laboratory prove that the written workflow matches actual practice?

If the answer to any question is unclear, the system has an exposed edge.

The goal is not to create a laboratory where contamination is theoretically impossible. The goal is to create one where contamination is difficult to introduce, difficult to spread, and quick to detect.

Conclusion: Trust Is Designed Before the Result Is Reported

A PCR result begins long before the thermal cycler starts.

It begins with the path a person takes through the laboratory. It begins with whether a pipette has a permanent home. It begins with whether a positive control is kept away from fresh reagents and whether an amplified tube can ever travel backward.

The three-room strategy gives those decisions a physical structure:

  • The Clean room protects the reaction.
  • The Grey room manages the biological sample.
  • The Dirty room contains amplification products.
  • The unidirectional workflow protects the entire system.

When supported by appropriate airflow, dedicated equipment, enzymatic controls, negative controls, cleaning, and disciplined training, this structure turns PCR sensitivity from a liability into a dependable diagnostic advantage.

For materials, technical guidance, and workflow support across the IVD development journey, connect with Contact Our Experts.

Related Products

Related Products

Anti-PHC3 Rabbit Polyclonal Antibody for IF/ICC, ELISA - Q8NDX5

Anti-PHC3 Rabbit Polyclonal Antibody for IF/ICC, ELISA - Q8NDX5

Rabbit polyclonal antibody against human PHC3, validated for IF/ICC and ELISA. Targets the polyhomeotic-like protein 3, a component of the PRC1 complex, for epigenetic and developmental biology research.

Anti-MRPL13 Polyclonal Antibody for WB, IHC-P, ELISA - Q9BYD1

Anti-MRPL13 Polyclonal Antibody for WB, IHC-P, ELISA - Q9BYD1

MRPL13 rabbit polyclonal antibody validated for WB, IHC-P, ELISA with cross-reactivity to human, mouse, rat. Suitable for mitochondrial ribosome studies, protein expression analysis, and immunohistochemistry.

Anti-MRPS30 Polyclonal Antibody for WB, IF/ICC, IP, ELISA - Q9NP92

Anti-MRPS30 Polyclonal Antibody for WB, IF/ICC, IP, ELISA - Q9NP92

High-quality rabbit polyclonal antibody against human MRPS30 (also known as PAP, PDCD9, S30mt). Validated for WB, IF/ICC, IP, ELISA applications. Reacts with human, mouse, rat mitochondrial ribosomal protein mL65.

Anti-p63 Rabbit Polyclonal Antibody for WB, IF-P, IHC-P, ELISA - Q9H3D4

Anti-p63 Rabbit Polyclonal Antibody for WB, IF-P, IHC-P, ELISA - Q9H3D4

Rabbit polyclonal antibody against human p63 (TP63), suitable for WB, IF-P, IHC-P, ELISA. Recognizes human, mouse, rat. Ideal for transcription regulation and epithelial morphogenesis research.

Anti-PLD3 Polyclonal Antibody for WB, IF/ICC, ELISA - Q8IV08

Anti-PLD3 Polyclonal Antibody for WB, IF/ICC, ELISA - Q8IV08

Rabbit polyclonal antibody targeting human PLD3, validated for WB, IF/ICC, ELISA; cross-reacts with mouse. Ideal for studying lysosomal exonuclease function, innate immunity, and nucleic-acid sensing.

Anti-BRCA1 Polyclonal Antibody for WB, IHC-P, IF/ICC, ELISA - P38398

Anti-BRCA1 Polyclonal Antibody for WB, IHC-P, IF/ICC, ELISA - P38398

Rabbit polyclonal antibody against human BRCA1 for WB, IHC-P, IF/ICC, and ELISA. Recognizes human BRCA1; ~208 kDa. Suitable for DNA damage repair and cancer research applications.

Anti-RPL35 Polyclonal Antibody for WB, IHC-P, IF/ICC, ELISA - P42766

Anti-RPL35 Polyclonal Antibody for WB, IHC-P, IF/ICC, ELISA - P42766

Rabbit polyclonal antibody against human RPL35 (60S ribosomal protein L35), validated for WB, IHC-P, IF/ICC, ELISA. Cross-reacts with mouse and rat. Ideal for ribosome research and protein synthesis studies.

Anti-MRPL38 Rabbit Polyclonal Antibody for WB, IHC-P, ELISA - Q96DV4

Anti-MRPL38 Rabbit Polyclonal Antibody for WB, IHC-P, ELISA - Q96DV4

High-quality anti-MRPL38 rabbit polyclonal antibody validated for WB, IHC-P, ELISA. Detects human, mouse, and rat MRPL38, a mitochondrial large ribosomal subunit protein. Ideal for mitochondrial translation and protein expression studies.

Anti-XRCC3 Rabbit Polyclonal Antibody for WB and ELISA - O43542

Anti-XRCC3 Rabbit Polyclonal Antibody for WB and ELISA - O43542

High-quality rabbit polyclonal antibody targeting human XRCC3, a key DNA repair protein. Validated for Western blot and ELISA applications. Ideal for homologous recombination and genomic stability research.

Anti-Proteinase 3/PR3 Rabbit Polyclonal Antibody for WB, ELISA - P24158

Anti-Proteinase 3/PR3 Rabbit Polyclonal Antibody for WB, ELISA - P24158

High-quality rabbit polyclonal antibody targeting human Proteinase 3/PR3 (Myeloblastin), suitable for WB and ELISA with cross-reactivity to rat. Ideal for inflammation, neutrophil biology, and autoimmune research.

Anti-RPL36A Polyclonal Antibody for WB, ELISA - P83881

Anti-RPL36A Polyclonal Antibody for WB, ELISA - P83881

Rabbit polyclonal antibody targeting human RPL36A (eL42, L44L). Validated for Western blot and ELISA. Suitable for ribosomal protein analysis, cell growth, and migration research.

Anti-MRPL39 Polyclonal Antibody for WB - Q9NYK5

Anti-MRPL39 Polyclonal Antibody for WB - Q9NYK5

Rabbit polyclonal antibody specific to MRPL39, a mitochondrial large ribosomal subunit protein. Validated for WB and ELISA analysis in human, mouse, and rat samples. Ideal for mitochondrial translation studies.

Anti-POLR3C Polyclonal Antibody for WB, ELISA - Q9BUI4

Anti-POLR3C Polyclonal Antibody for WB, ELISA - Q9BUI4

POLR3C Rabbit pAb validated for WB and ELISA. Reacts with human, mouse, rat. Targets RNA Polymerase III subunit RPC3 (RPC62), a DNA sensor and transcription component. Ideal for innate immunity and transcription research.

Anti-POLR1C Rabbit Polyclonal Antibody for WB and ELISA - O15160

Anti-POLR1C Rabbit Polyclonal Antibody for WB and ELISA - O15160

Rabbit polyclonal antibody targeting human POLR1C (RPAC1), validated for Western blot and ELISA. Essential for studying RNA polymerase I/III transcription, nucleolar function, and leukodystrophy-related pathways. - O15160

Anti-RPS3 Polyclonal Antibody for WB, IF/ICC, ELISA - P23396

Anti-RPS3 Polyclonal Antibody for WB, IF/ICC, ELISA - P23396

Rabbit polyclonal antibody against human RPS3, validated for WB, IF/ICC, and ELISA. Reacts with human, mouse, and rat samples. Suitable for ribosomal protein detection and DNA repair studies.

Anti-POLR3F Polyclonal Antibody for WB and ELISA - Q9H1D9

Anti-POLR3F Polyclonal Antibody for WB and ELISA - Q9H1D9

Rabbit polyclonal antibody targeting human POLR3F (RPC6, RPC39), validated for WB and ELISA. Cross-reacts with mouse and rat. Detects a 36kDa band, suitable for RNA polymerase III research and innate immunity studies.

Anti-RPL36AL Polyclonal Antibody for WB, IF/ICC, ELISA - Q969Q0

Rabbit polyclonal antibody against human RPL36AL (60S ribosomal protein L36a-like), suitable for western blot, immunofluorescence, and ELISA. Cross-reacts with mouse and rat. Ideal for ribosomal protein and translation studies.

Anti-Prion Protein Polyclonal Antibody for WB, ELISA - P04156

Anti-Prion Protein Polyclonal Antibody for WB, ELISA - P04156

Rabbit polyclonal antibody targeting human Prion Protein (PRNP). Validated for Western blot and ELISA, cross-reacts with mouse. Useful for research on prion diseases, neuronal development, and iron homeostasis.

Anti-RFC3 Polyclonal Antibody for WB and ELISA - P40938

Anti-RFC3 Polyclonal Antibody for WB and ELISA - P40938

Rabbit polyclonal antibody targeting human RFC3, validated for Western blot and ELISA applications. Detects RFC3 in human, mouse, and rat samples. Essential for DNA replication and PCNA loading research.

Anti-PTP4A3 Polyclonal Antibody for WB, IHC-P, ELISA - O75365

Anti-PTP4A3 Polyclonal Antibody for WB, IHC-P, ELISA - O75365

Rabbit polyclonal antibody targeting human PTP4A3 (PRL-3), validated for WB, IHC-P, and ELISA. Cross-reacts with mouse. Ideal for cancer metastasis, cell proliferation, and cardiac hypertrophy research.


Leave Your Message